Prospera Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.56M | Buy |
10,235
+7,204
| +238% | +$3.21M | 0.08% | 241 |
|
|
2025
Q1 | $1.47M | Sell |
3,031
-271
| -8% | -$131K | 0.03% | 456 |
|
|
2024
Q4 | $1.33M | Sell |
3,302
-10,196
| -76% | -$4.11M | 0.03% | 468 |
|
|
2024
Q3 | $6.28M | Buy |
13,498
+10,951
| +430% | +$5.09M | 0.16% | 141 |
|
|
2024
Q2 | $1.19M | Sell |
2,547
-196
| -7% | -$91.9K | 0.03% | 461 |
|
|
2024
Q1 | $1.15M | Buy |
2,743
+125
| +5% | +$52.3K | 0.03% | 462 |
|
|
2023
Q4 | $1.07M | Sell |
2,618
-51
| -2% | -$20.8K | 0.04% | 456 |
|
|
2023
Q3 | $928K | Buy |
2,669
+38
| +1% | +$13.2K | 0.04% | 433 |
|
|
2023
Q2 | $926K | Buy |
2,631
+4
| +0.2% | +$1.41K | 0.04% | 438 |
|
|
2023
Q1 | $828K | Buy |
2,627
+65
| +3% | +$20.5K | 0.03% | 479 |
|
|
2022
Q4 | $740K | Buy |
2,562
+87
| +4% | +$25.1K | 0.04% | 434 |
|
|
2022
Q3 | $716K | Buy |
2,475
+230
| +10% | +$66.5K | 0.04% | 442 |
|
|
2022
Q2 | $633K | Buy |
2,245
+566
| +34% | +$160K | 0.03% | 462 |
|
|
2022
Q1 | $438K | Buy |
+1,679
| New | +$438K | 0.02% | 636 |
|
|
2020
Q4 | – | Sell |
-157
| Closed | -$43K | – | 1558 |
|
|
2020
Q3 | $43K | Sell |
157
-535
| -77% | -$147K | 0.02% | 674 |
|
|
2020
Q2 | $201K | Buy |
+692
| New | +$201K | 0.02% | 538 |
|